Skip to main content
. Author manuscript; available in PMC: 2019 Mar 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2017 Dec 9;100(4):882–890. doi: 10.1016/j.ijrobp.2017.11.047

Table 3.

CanSORT Satisfaction with Breast Cosmetic Outcome and BREAST-Q Satisfaction with Breast scores

CanSORT* (n = 477)
BREAST-Q,§ (n = 451)
n Mean (95% CI) P value n Mean (95% CI) P value
Lump + WBI 107 3.40 (3.14–3.67) Referent 104 60.00 (53.04–66.95) Referent
Lump + Brachy 101 3.77 (3.54–4.00) .007   98 66.95 (59.85–74.04) .03  
Lump alone   74 3.80 (3.50–4.09) .045   71 67.82 (57.48–78.17) .12  
Mast alone   87 3.11 (2.83–3.40) .06     82 59.27 (51.83–66.72) .83  
Mast + RT 108 3.01 (2.77–3.25) .006   96 50.24 (43.62–56.85) .001

Abbreviations: CanSORT = Cancer Surveillance and Outcomes Research Team; CI = confidence interval; Lump alone = lumpectomy plus endocrine therapy alone; Lump + Brachy = lumpectomy plus brachytherapy; Lump + WBI = lumpectomy plus whole-breast irradiation; Mast alone = mastectomy alone; Mast + RT = mastectomy plus radiation therapy.

*

The final model for the CanSORT instrument was adjusted for Charlson Comorbidity Index.

Patients were included if they had ≥1 nonmissing response to the CanSORT instrument.

The final model for BREAST-Q Satisfaction with Breast was adjusted for race, Charlson Comorbidity Index, and patient-reported endocrine therapy.

§

CanSORT and BREAST-Q satisfaction scores were highly correlated with each other (Spearman coefficient = 0.8, P < .001).

Patients were included if they had ≥50% nonmissing responses; missing responses were assigned a value based on the mean of the nonmissing responses (in accordance with BREAST-Q scoring tables).